Li L, Mok H, Jhaveri P, Bonnen M, Sikora A, Eissa N
Expert Rev Anticancer Ther. 2018; 18(10):1041-1057.
PMID: 29996062
PMC: 6290681.
DOI: 10.1080/14737140.2018.1500180.
Bonanni A, Calatroni M, DAlessandro M, Signa S, Bertelli E, Cioni M
Br J Clin Pharmacol. 2018; 84(6):1238-1249.
PMID: 29436729
PMC: 5980330.
DOI: 10.1111/bcp.13548.
Souza F, Smith A, Araujo C, Jagannathan J, Johnston C, ORegan K
Cancer Imaging. 2015; 14:26.
PMID: 25608887
PMC: 4331831.
DOI: 10.1186/1470-7330-14-26.
Ergin A, Fong N, Daw H
Case Rep Med. 2012; 2012:680431.
PMID: 22778751
PMC: 3388422.
DOI: 10.1155/2012/680431.
Barber N, Ganti A
Target Oncol. 2011; 6(4):235-43.
PMID: 22076388
DOI: 10.1007/s11523-011-0199-0.
Severe pulmonary adverse effects in lymphoma patients treated with cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) regimen plus rituximab.
Lim K, Yoon H, Kang Y, Lee K, Kim J, Bang S
Korean J Intern Med. 2010; 25(1):86-92.
PMID: 20195409
PMC: 2829422.
DOI: 10.3904/kjim.2010.25.1.86.
[Anti-B-cell strategies in vasculitides and collagenoses].
Rubbert-Roth A
Z Rheumatol. 2009; 68(5):390-6.
PMID: 19551392
DOI: 10.1007/s00393-009-0439-1.
Fatal pulmonary fibrosis after rituximab administration.
Chaumais M, Garnier A, Chalard F, Peuchmaur M, Dauger S, Jacqz-Agrain E
Pediatr Nephrol. 2009; 24(9):1753-5.
PMID: 19396468
DOI: 10.1007/s00467-009-1195-9.
Neglected respiratory toxicity caused by cancer therapy.
Domingo C, Roig J
Open Respir Med J. 2009; 1:1-6.
PMID: 19340316
PMC: 2596356.
DOI: 10.2174/1874306400701010001.
Rituximab-induced hypersensitivity pneumonitis.
Tonelli A, Lottenberg R, Allan R, Sriram P
Respiration. 2008; 78(2):225-9.
PMID: 18843175
PMC: 2790794.
DOI: 10.1159/000163069.
Infiltrative lung diseases: complications of novel antineoplastic agents in patients with hematological malignancies.
Vahid B, Marik P
Can Respir J. 2008; 15(4):211-6.
PMID: 18551203
PMC: 2677954.
DOI: 10.1155/2008/305234.
Increased incidence of interstitial pneumonia by CHOP combined with rituximab.
Ennishi D, Terui Y, Yokoyama M, Mishima Y, Takahashi S, Takeuchi K
Int J Hematol. 2008; 87(4):393-397.
PMID: 18409079
DOI: 10.1007/s12185-008-0066-7.
Two cases of interstitial pneumonitis caused by rituximab therapy.
Lee Y, Kyung S, Choi S, Bang S, Jeong S, Shin D
Korean J Intern Med. 2006; 21(3):183-6.
PMID: 17017668
PMC: 3890722.
DOI: 10.3904/kjim.2006.21.3.183.
Acute respiratory distress syndrome after rituximab infusion.
Montero A, McCarthy J, Chen G, Rice L
Int J Hematol. 2005; 82(4):324-6.
PMID: 16298824
PMC: 7101654.
DOI: 10.1532/IJH97.NA0506.
